Cardiac Electrophysiology Review,volume 7,issue 3  (09-2003)

Period of time： 2003年3期

Publisher： Springer Publishing Company

Founded in： 1997

Total resources： 4

ISSN： 1385-2264

Subject： R5 Internal Medicine

Favorite

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Cardiac Electrophysiology Review,volume 7,issue 3

Menu

Significance of Atrial Fibrillation During Acute Myocardial Infarction, and its Current Management: Insights from the GUSTO-3 Trial

By Wong C-K. in (2003)

Cardiac Electrophysiology Review,volume 7,issue 3 , Vol. 7, Iss. 3, 2003-09 , pp. 201-207

Springer Publishing Company

Abstract Access to resources Recommend Favorite

Rationale for the Atrial Fibrillation and Congestive Heart Failure (AF-CHF) Trial

By Roy D. in (2003)

Cardiac Electrophysiology Review,volume 7,issue 3 , Vol. 7, Iss. 3, 2003-09 , pp. 208-210

Springer Publishing Company

Abstract Access to resources Recommend Favorite

Cost Evaluation of Rhythm Control Methods for Atrial Fibrillation: Evidence from CTAF

By Nattel S. in (2003)

Cardiac Electrophysiology Review,volume 7,issue 3 , Vol. 7, Iss. 3, 2003-09 , pp. 211-214

Springer Publishing Company

Abstract Access to resources Recommend Favorite

Azimilide for Atrial Fibrillation: Clinical Trial Results and Implications

By Pritchett E.L.C. in (2003)

Cardiac Electrophysiology Review,volume 7,issue 3 , Vol. 7, Iss. 3, 2003-09 , pp. 215-219

Springer Publishing Company

Abstract Access to resources Recommend Favorite

Does Conversion and Prevention of Atrial Fibrillation Enhance Survival in Patients with Left Ventricular Dysfunction? Evidence from the Danish Investigations of Arrhythmia and Mortality ON Dofetilide/(DIAMOND) Study

By Pedersen O.D. in (2003)

Cardiac Electrophysiology Review,volume 7,issue 3 , Vol. 7, Iss. 3, 2003-09 , pp. 220-224

Springer Publishing Company

Abstract Access to resources Recommend Favorite

Role of Dofetilide in Patients with Atrial Fibrillation. Insights from the Symptomatic Atrial Fibrillation Investigative Research on Dofetilide (SAFIRE-D) Study

By Singh S.N. in (2003)

Cardiac Electrophysiology Review,volume 7,issue 3 , Vol. 7, Iss. 3, 2003-09 , pp. 225-228

Springer Publishing Company

Abstract Access to resources Recommend Favorite

Beta Blockers Improve Outcome in Patients with Heart Failure and Atrial Fibrillation: U.S. Carvedilol Study

By Ramaswamy K. in (2003)

Cardiac Electrophysiology Review,volume 7,issue 3 , Vol. 7, Iss. 3, 2003-09 , pp. 229-232

Springer Publishing Company

Abstract Access to resources Recommend Favorite

Beta-Blocker Efficacy According to Heart Rate and Rhythm in Patients with Heart Failure. Commentary on the Cardiac Insufficiency Bisoprolol Study II Analysis

By Lechat P.P. in (2003)

Cardiac Electrophysiology Review,volume 7,issue 3 , Vol. 7, Iss. 3, 2003-09 , pp. 233-235

Springer Publishing Company

Abstract Access to resources Recommend Favorite

Role of Beta-Blocker Therapy in Heart Failure and Atrial Fibrillation

By Fung J.W.H. in (2003)

Cardiac Electrophysiology Review,volume 7,issue 3 , Vol. 7, Iss. 3, 2003-09 , pp. 236-242

Springer Publishing Company

Abstract Access to resources Recommend Favorite

Angiotensin Receptor Blocker as Adjunctive Therapy for Rhythm Control in Atrial Fibrillation: Results of the Irbesartan-Amiodarone Trial

By Madrid A.H. in (2003)

Cardiac Electrophysiology Review,volume 7,issue 3 , Vol. 7, Iss. 3, 2003-09 , pp. 243-246

Springer Publishing Company

Abstract Access to resources Recommend Favorite

Previous 1 2 3 Next Display item(s) per page Total 21 item(s)